Point-of-Care Coagulation (POCC) Testing Devices Market Size, Share & Industry Analysis, By Device Type (Anticoagulation Monitoring Devices {Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPPT)}, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices {Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)}, and Others), By End User (Hospitals & Clinics, Homecare Settings, and Others), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth rate

CAGR of 7.5% from 2025-2032

Unit

Value (USD billion)

Segmentation

By Device Type

• Anticoagulation Monitoring Devices
  • Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices
  • Activated Clotting Time (ACT)
  • Activated Partial Thromboplastin Time (aPTT)
• Platelet Function Monitoring Devices
• Viscoelastic Coagulation Monitoring Devices
  • Thromboelastography (TEG)
  • Rotational Thromboelastometry (ROTEM)
• Others

By End User

• Hospitals & Clinics
• Homecare Settings
• Others

By Region

• North America (by Device Type, by End User, by Country)
  • U.S.
  • Canada
• Europe (by Device Type, by End User, by Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (by Device Type, by End User, by Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of the Asia Pacific
• Latin America (by Device Type, by End User, by Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (by Device Type, by End User, by Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa